Class Action Filed Against Elanco Animal Health Incorporated (ELAN) Seeking Recovery for Investors - Contact The Gross Law Firm

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Elanco Animal Health Incorporated regarding a class action lawsuit due to alleged misleading statements and omissions related to product safety and approval timelines [1][2]. Group 1: Allegations and Class Period - The class period for the lawsuit is from November 7, 2023, to June 26, 2024 [2]. - Allegations include that Elanco misrepresented the safety of Zenrelia, a canine dermatology product, and was unlikely to meet its own timeline for U.S. approval and launch of Zenrelia and Credelio Quattro [2]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by December 6, 2024, to potentially become lead plaintiffs [3]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [4].